drug

lepodisiran

Status: Investigational
Code: LY3819469
Trials: 3 registered trials in coverage

Relationships

Targets Lipoprotein(a)

Developed by Eli Lilly

Also known as

lepodisiran sodium

Timeline

No published stories yet.

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.